Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
Current Cancer Drug Targets
|
March 12, 2009
The novel RARbeta isoform (beta5) is a potential target of retinoids in breast cancer
Konstantin Christov
Anticancer Research
|
August 23, 2003
Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency
Steven M Swanson, Konstantin Christov
International Journal of Oncology
|
May 23, 2015
Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review)
Anne Shilkaitis, Albert Green, Konstantin Christov
International Journal of Oncology
|
September 18, 2004
Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids
Xinjian Peng, Duri Yun, Konstantin Christov
Oncology Reports
|
June 6, 2007
Anti-progestins suppress the growth of established tumors induced by 7,12-dimethylbenz(a)anthracene: comparison between RU486 and a new 21-substituted-19-nor-progestin
Ronald D Wiehle, Konstantin Christov, Rajendra Mehta
Cancer Prevention Research (Philadelphia, Pa.)
|
December 2, 2010
CDB-4124, a progesterone receptor modulator, inhibits mammary carcinogenesis by suppressing cell proliferation and inducing apoptosis
Ronald Wiehle, Daniel Lantvit, Tohru Yamada, et al.
Neoplasia (New York, N.Y.)
|
May 3, 2011
Cdk2-null mice are resistant to ErbB-2-induced mammary tumorigenesis
Dipankar Ray, Yasuhisa Terao, Konstantin Christov, et al.
Cancer Letters
|
May 3, 2005
Retinoids suppress premalignant MCF10AT but not malignant MCF10CA1a breast epithelial cells in vivo. Role of retinoic acid receptor beta2 expression
Xinjian Peng, Steven Wood, Laura Bratescu, et al.
Oncogene
|
November 24, 2004
Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells
Xinjian Peng, Rajendra G Mehta, Debra A Tonetti, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 23, 2013
Bexarotene induces cellular senescence in MMTV-Neu mouse model of mammary carcinogenesis
Anne Shilkaitis, Laura Bratescu, Albert Green, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
Current Cancer Drug Targets
|
March 12, 2009
The novel RARbeta isoform (beta5) is a potential target of retinoids in breast cancer
Konstantin Christov
Anticancer Research
|
August 23, 2003
Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency
Steven M Swanson, Konstantin Christov
International Journal of Oncology
|
May 23, 2015
Retinoids induce cellular senescence in breast cancer cells by RAR-β dependent and independent pathways: Potential clinical implications (Review)
Anne Shilkaitis, Albert Green, Konstantin Christov
International Journal of Oncology
|
September 18, 2004
Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids
Xinjian Peng, Duri Yun, Konstantin Christov
Oncology Reports
|
June 6, 2007
Anti-progestins suppress the growth of established tumors induced by 7,12-dimethylbenz(a)anthracene: comparison between RU486 and a new 21-substituted-19-nor-progestin
Ronald D Wiehle, Konstantin Christov, Rajendra Mehta
Cancer Prevention Research (Philadelphia, Pa.)
|
December 2, 2010
CDB-4124, a progesterone receptor modulator, inhibits mammary carcinogenesis by suppressing cell proliferation and inducing apoptosis
Ronald Wiehle, Daniel Lantvit, Tohru Yamada, et al.
Neoplasia (New York, N.Y.)
|
May 3, 2011
Cdk2-null mice are resistant to ErbB-2-induced mammary tumorigenesis
Dipankar Ray, Yasuhisa Terao, Konstantin Christov, et al.
Cancer Letters
|
May 3, 2005
Retinoids suppress premalignant MCF10AT but not malignant MCF10CA1a breast epithelial cells in vivo. Role of retinoic acid receptor beta2 expression
Xinjian Peng, Steven Wood, Laura Bratescu, et al.
Oncogene
|
November 24, 2004
Identification of novel RARbeta2 transcript variants with short 5'-UTRs in normal and cancerous breast epithelial cells
Xinjian Peng, Rajendra G Mehta, Debra A Tonetti, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
February 23, 2013
Bexarotene induces cellular senescence in MMTV-Neu mouse model of mammary carcinogenesis
Anne Shilkaitis, Laura Bratescu, Albert Green, et al.
Page
of 5